Geller Matthew

Director at BIOSPECIFICS TECHNOLOGIES CORP

Sold, on record
$725k
Dollars the filings state
Form 4 sales
3
Latest Jun 7, 2011
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusual
    May 23 2011

    Sold 12,300 shares at $24.01 ($295k)

    Geller Matthew, Director

    Sold 41% of holdings ($720k position)17,700 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusual
    May 24 +1 day

    Sold 7,700 shares at $24.08 ($185k)

    Geller Matthew, Director

    Sold 43.5% of holdings ($426k position)10,000 shares leftFiling

  3. 3 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusual
    Jun 7 +14 days

    Sold 10,000 shares at $24.40 ($244k)

    Geller Matthew, Director

    Sold 100% of holdings ($244k position)0 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Geller Matthew
Source
Jun 7, 2011BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale10,000$244k100.0%UnusualSEC
May 24, 2011BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale7,700$185k43.5%UnusualSEC
May 23, 2011BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale12,300$295k41.0%UnusualSEC